United Therapeutics director Causey sells $440k in UTHR stock
NegativeFinancial Markets

In a significant move, United Therapeutics director Causey has sold $440,000 worth of UTHR stock. This sale raises eyebrows as it may indicate a lack of confidence in the company's future performance. Such actions by insiders can often lead to speculation and concern among investors, potentially impacting the stock's value.
— Curated by the World Pulse Now AI Editorial System